Core Viewpoint - Rosen Law Firm has filed a class action lawsuit on behalf of purchasers of Klarna Group plc securities related to its September 2025 IPO, alleging misleading statements in the Registration Statement [1][5]. Group 1: Lawsuit Details - The lawsuit claims that the Registration Statement contained false and/or misleading statements and failed to disclose the risk of increased loss reserves shortly after the IPO, which was known or should have been known by the defendants [5]. - Investors are entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. Group 2: Participation Information - Interested parties can join the class action by visiting the provided link or contacting the law firm directly [3][6]. - A lead plaintiff must move the Court by February 20, 2026, to represent other class members in the litigation [1][3]. Group 3: Law Firm Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements, including the largest against a Chinese company at the time [4]. - The firm has been consistently ranked among the top firms for securities class action settlements and has recovered hundreds of millions for investors [4].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Perrigo Company plc securities between February 27, 2023, and November 4, 2025, of the upcoming lead plaintiff deadline on January 16, 2026, for a class action lawsuit [1]. Group 1: Class Action Details - Investors who bought Perrigo securities during the specified class period may be eligible for compensation without any out-of-pocket fees through a contingency fee arrangement [1]. - A class action lawsuit has already been filed, and those wishing to serve as lead plaintiff must file with the court by January 16, 2026 [2]. Group 2: Law Firm Credentials - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions, highlighting its own achievements, including the largest securities class action settlement against a Chinese company [3]. - The firm has consistently ranked in the top 4 for securities class action settlements since 2013 and recovered hundreds of millions of dollars for investors, including over $438 million in 2019 [3]. Group 3: Case Allegations - The lawsuit alleges that Perrigo made materially false and misleading statements regarding its infant formula business, including significant underinvestment in maintenance and the need for substantial capital expenditures [4]. - It is claimed that these misstatements led to overstated financial results, including earnings and cash flow, which misled investors about the company's operations and prospects [4].

NEW YORK, Dec. 19, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of CarMax, Inc. (NYSE: KMX) between June 20, 2025 and November 5, 2025, both dates inclusive (the “Class Period”) of the important January 2, 2026 lead plaintiff deadline in the securities class action first filed by the Firm. SO WHAT: If you purchased CarMax securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or co ...

Core Viewpoint - Rosen Law Firm is investigating potential securities claims on behalf of shareholders of Tandem Diabetes Care, Inc. due to allegations of materially misleading business information issued by the company [1]. Group 1: Investigation and Legal Action - Shareholders who purchased Tandem Diabetes securities may be entitled to compensation through a class action lawsuit without any out-of-pocket fees [2]. - The Rosen Law Firm is preparing a class action to seek recovery of investor losses related to the allegations against Tandem Diabetes [2]. Group 2: Company Incident - On August 7, 2025, Tandem Diabetes issued a press release regarding a voluntary medical device correction for select t:slim X2 insulin pumps, addressing a potential speaker-related issue that could lead to insulin delivery discontinuation [3]. - Following this announcement, Tandem Diabetes' stock experienced a significant decline of 19.9% on the same day [3]. Group 3: Rosen Law Firm's Credentials - The Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions [4]. - The firm has achieved notable settlements, including the largest securities class action settlement against a Chinese company and has consistently ranked highly in securities class action settlements since 2013 [4]. - In 2019, the firm secured over $438 million for investors, showcasing its capability in recovering significant amounts for its clients [4].

Core Viewpoint - A class action lawsuit has been filed against Integer Holdings Corporation for allegedly making materially false and misleading statements regarding its competitive position and sales performance in the electrophysiology manufacturing market during the specified Class Period from July 25, 2024, to October 22, 2025 [1][5]. Group 1: Lawsuit Details - The lawsuit claims that Integer overstated its competitive position in the electrophysiology manufacturing market and mischaracterized its EP devices as long-term growth drivers for its cardio and vascular segment [5]. - It is alleged that Integer experienced a deterioration in sales for two of its EP devices, contradicting its claims of strong customer demand [5]. - The lawsuit asserts that the positive statements made by the defendants about Integer's business and prospects were materially false and misleading, leading to investor damages when the true information became public [5]. Group 2: Participation Information - Investors who purchased Integer common stock during the Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - To join the class action, interested parties can visit the provided link or contact the law firm for more information [3][6]. - A lead plaintiff must file a motion with the court by February 9, 2026, to represent other class members in the litigation [1][3]. Group 3: Law Firm Credentials - The Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements, including the largest securities class action settlement against a Chinese company [4]. - The firm has been consistently ranked among the top firms for securities class action settlements and has recovered hundreds of millions of dollars for investors [4]. - In 2019, the firm secured over $438 million for investors, showcasing its capability in handling such cases [4].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Blue Owl Capital Inc. securities between February 6, 2025, and November 16, 2025, about the upcoming lead plaintiff deadline on February 2, 2026, for a class action lawsuit [1]. Group 1: Class Action Details - Investors who bought Blue Owl securities during the specified Class Period may be eligible for compensation without incurring out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties can join by contacting Rosen Law Firm [3][6]. - To serve as lead plaintiff, individuals must file a motion with the Court by February 2, 2026 [3]. Group 2: Case Allegations - The lawsuit alleges that during the Class Period, Blue Owl made false or misleading statements and failed to disclose significant issues, including pressure on its asset base from BDC redemptions and undisclosed liquidity problems [5]. - It is claimed that Blue Owl was likely to limit or halt redemptions of certain BDCs, and the defendants downplayed the severity of these issues, leading to materially misleading positive statements about the company's business and prospects [5].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Telix Pharmaceuticals Ltd. securities between February 21, 2025, and August 28, 2025, about the upcoming lead plaintiff deadline for a securities class action lawsuit [1] Group 1: Class Action Details - Investors who bought Telix securities during the specified Class Period may be eligible for compensation without any out-of-pocket fees through a contingency fee arrangement [2] - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by January 9, 2026 [3] - The lawsuit alleges that defendants made materially false and misleading statements regarding Telix's progress in prostate cancer therapeutic candidates and the quality of its supply chain [5] Group 2: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions [4] - The firm has achieved significant settlements, including the largest securities class action settlement against a Chinese company, and has recovered hundreds of millions of dollars for investors [4] - In 2019, the firm secured over $438 million for investors, showcasing its effectiveness in litigation [4]

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Stride, Inc. securities during the specified Class Period of the upcoming lead plaintiff deadline for a class action lawsuit [1][2]. Group 1: Class Action Details - The Class Period for the Stride securities is from October 22, 2024, to October 28, 2025, and the lead plaintiff deadline is January 12, 2026 [1]. - Investors who purchased Stride securities during this period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1]. Group 2: Legal Representation - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions [3]. - The firm has achieved significant settlements, including the largest securities class action settlement against a Chinese company, and has consistently ranked highly in securities class action settlements since 2013 [3]. Group 3: Allegations Against Stride, Inc. - The lawsuit alleges that Stride made misleading statements regarding its products and services, inflating enrollment numbers, cutting staff costs excessively, and failing to comply with requirements, which led to investor damages when the truth was revealed [4].

Core Viewpoint - A class action lawsuit has been filed against DeFi Technologies, Inc. for misleading statements regarding its financial performance and business operations during the specified Class Period from May 12, 2025, to November 14, 2025 [1][5]. Group 1: Lawsuit Details - The lawsuit claims that DeFi Technologies made false and misleading statements about delays in executing its DeFi arbitrage strategy, which is a key revenue driver [5]. - It is alleged that the company understated the competition it faced from other digital asset treasury companies, impacting its ability to execute its strategy [5]. - The lawsuit indicates that DeFi Technologies was unlikely to meet its previously issued revenue guidance for the fiscal year 2025 due to these issues [5]. Group 2: Investor Information - Investors who purchased DeFi Technologies securities during the Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - Interested investors can join the class action by visiting the provided link or contacting the law firm directly [3][6]. Group 3: Law Firm Credentials - The Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements, including the largest securities class action settlement against a Chinese company [4]. - The firm has been consistently ranked among the top firms for securities class action settlements and has recovered hundreds of millions of dollars for investors [4].

Core Viewpoint - A class action lawsuit has been filed against Blue Owl Capital Inc. for misleading statements regarding its financial health and liquidity issues during the specified Class Period from February 6, 2025, to November 16, 2025 [1][5]. Group 1: Lawsuit Details - The lawsuit claims that Blue Owl made false or misleading statements and failed to disclose significant pressures on its asset base due to business development companies (BDC) redemptions, leading to undisclosed liquidity issues [5]. - It is alleged that Blue Owl was likely to limit or halt redemptions of certain BDCs, and that the defendants downplayed the severity of the negative impacts, resulting in materially misleading statements about the company's business and prospects [5]. Group 2: Investor Information - Investors who purchased Blue Owl securities during the Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - To participate in the class action, investors can visit the provided link or contact the law firm for more information [3][6]. Group 3: Law Firm Credentials - The Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements, including the largest securities class action settlement against a Chinese company [4]. - The firm has consistently ranked highly in securities class action settlements and has recovered hundreds of millions of dollars for investors, with over $438 million secured in 2019 alone [4].